Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiorenal mechanisms of action of glucagon-like-peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors

Published:2021-11 Issue:11 Volume:2 Page:1203-1230
ISSN:2666-6340
Container-title:Med
language:en
Short-container-title:Med

Author:

Cherney David Z.I.,Udell Jacob A.^ORCID,Drucker Daniel J.^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference267 articles.

1. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2006

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33);Lancet,1998

3. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N. Engl. J. Med.,2008

4. Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes;Holman;Lancet,2014

5. Assessing the cardiovascular safety of diabetes therapies;Goldfine;N. Engl. J. Med.,2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Semaglutide on Cardiac Structure and Function in Patients With Obesity-Related Heart Failure;Journal of the American College of Cardiology;2024-08

2. Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial;Journal of the American College of Cardiology;2024-08

3. Unveiling the Potential Role of Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists in Offering Protection of the Cardiovascular, Renal, and Neural Systems: An Updated Narrative Review;Cureus;2024-07-31

4. Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists;Cardiovascular Diabetology;2024-07-29

5. Heart failure with preserved ejection fraction therapy: combining sodium-glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists;European Heart Journal;2024-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3